108
Participants
Start Date
March 1, 2025
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2028
Psilocybin therapy
Psilocybin therapy consisting of three preparation, two dosing, and three integration sessions. All sessions will take place in a controlled, safety environment and supported by two study therapists
Collaborators (3)
HumanKindLabs
UNKNOWN
University of Copenhagen
OTHER
CTC Clinical Trial Consultants AB
INDUSTRY
OPEN Foundation
UNKNOWN
IESE Business School
UNKNOWN
Uppsala University
OTHER
The Champalimaud Centre, Lisbon, Portugal
UNKNOWN
Stockholm University
OTHER
University of Groningen, The Netherlands
UNKNOWN
National Institute of Mental Health, Czech Republic
OTHER
European Association for Palliative Care (EAPC)
UNKNOWN
Madopa
UNKNOWN
Bispebjerg Hospital, Copenhagen, Denmark
UNKNOWN
European Association of Neurological Associations (EFNA)
UNKNOWN
29k International AB
UNKNOWN
Lung Alliance Netherlands
UNKNOWN
European Psychiatric Association
UNKNOWN
Norrsken Mind
UNKNOWN
University Medical Center Groningen
OTHER